In pharmaceutical manufacturing, operational efficiency is crucial for meeting production targets while ensuring product quality and cost-effectiveness.

One impactful strategy is increasing the number of cavities per nest for prefilable polymer syringes.

This enhancement maximizes conveyor space utilization, streamlines production processes, and supports sustainability objectives by minimizing material and energy consumption per unit.

Join us in this joint Pharmaversity® session with Bausch+Ströbel to discover how this simple yet impactful adjustment can lead to significant improvements in efficiency, cost-effectiveness, and environmental responsibility for pharmaceutical manufacturers.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Latest innovations in drug technologies seek to bring cancer treatment to the next level. For example, using the targeting ability of monoclonal antibodies in combination with a cytotoxic (Antibody Drug Conjugates) or radioactive molecule (Radionuclide Drug Conjugates). These medicines offer a promising alternative to common radiation or chemotherapy, potentially increasing effectiveness and reducing side effects for patients due to their precision.

However, these drugs have complex structures that pose certain challenges in processing and storage in primary packaging. Stability issues often necessitate lyophilization, while liquid formulations can be affected by glass leachables. Additionally, light sensitivity may present further hurdles. Join this Pharmaversity® session and learn what vial solutions SCHOTT Pharma offers to address these challenges.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Contamination control programming, as defined in EU Annex I, mitigates risk. This webinar highlights elements of the SCHOTT Pharma Contamination Control Strategy (CCS) and strategies for compliance with GMP standards. Integrating RTU containers with state-of-the-art filling concepts minimizes contamination risks, streamers validation processes, and enhances overall manufacturing efficiency. Compliance means aligning with regulations, optimizing processes, and elevating pharmaceutical manufacturing quality.

Learn more about your ad choices. Visit megaphone.fm/adchoices

The road to drug submission can feel like an existential question through a labyrinth with a blindfold—exciting yet slightly terrifying. This webinar will delve into the complexities of drug submission, illuminating the path with insights into Testing Services for Combination Drug Products.

Gain insights on streamlining your testing processes for regulatory compliance, accelerating your market submission, and elevating the assurance of your product’s quality and safety. Explore the capabilities of SCHOTT Pharma's PartnerLab, designed to transform intricate regulatory requirements into a seamless routine.

Learn more about your ad choices. Visit megaphone.fm/adchoices

mRNA. saRNA. DNA drugs. Only some of the groundbreaking medical developments that offer new possibilities for treating different diseases. The stability of these biological drugs, until they are injected, is mainly achieved with storage at deep-cold temperatures. This brings several significant challenges for pharmaceutical companies.

This webinar will explore the complexities of deep-cold requirements and unveil a novel glass solution – EVERIC® freeze. As the first glass vial with optimized strength for applications down to -80°C, EVERIC® freeze promises to redefine the biological drug storage landscape.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Larger subcutaneous injections are becoming more prominent due to recent advances in formulation development and new therapeutic areas. Therefore, novel large volume autoinjectors need to be developed to fulfill this new demand. As the interplay of device and container is crucial for a safe and reliable drug administration, a co-development between container and device manufacturers is a meaningful way to understand and address all relevant stakeholder needs.

In this Pharmaversity® session experts from SCHOTT Pharma and Ypsomed will provide an insight into how pharmaceutical requirements, user needs, processability, and business requirements have guided the co-development of YpsoMate 5.5 autoinjector and syriQ BioPure® 5.5ml prefillable glass syringe.

Learn more about your ad choices. Visit megaphone.fm/adchoices

A growing number of drugs like gene therapies, mRNA-, DNA- and viral vector vaccines require storage at deep cold temperatures. The functionality of the primary packaging is strongly impacted at these temperatures and limited market know-how is available.

In this Pharmaversity™ session our experts will provide insight in how low temperature storage can influence the primary packaging and a science-based data package providing deep-dive on the container's functionality helping you to make a sound decision when choosing the container. Two solutions will be presented: one based on vials with optimized strength for applications down to -80°C and one based on prefillable syringes suitable for storage down to -100°C.

Learn more about your ad choices. Visit megaphone.fm/adchoices

During pharma development, goal number one is to find a formulation that keeps the drug stable and hence safe for the future patient. The more formulation options you have, the higher the likelihood that you find the most appropriate solution for the specific drug along its life cycle. Later re-formulations due to stability issues as e.g. particle formation or pH shift are time- and cost intensive.

Learn in this session how EVERIC® pure, an enhanced Type I glass vial, increases your formulation options resulting in safer and faster time to market.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Ampoules were the first container developed to store injectable drugs. Still today is the most used container worldwide contributing to save lives around the globe.

Learn at this webinar how to improve your filling process and get insights about how you can cope with common challenges associated with ampoule processing and handling. From an end user perspective, we will have a look on how the use of SCHOTT ampoules can safeguard patients from the opening of the ampoule to the protection against counterfeit.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Today, most companies are aware of the need for future climate-neutral or net-zero pharmaceutical products. But, the question is how to get there. Our response is industry collaboration: With our partners in the Alliance to Zero we are conceptionalizing how the product carbon footprint of autoinjectors can be mitigated.

With this presentation, we take you with us on the journey to zero: starting from assessing the footprint of today, upcoming or needed future regulations to the concept and starting points of a future circular supply chain.

Learn more about your ad choices. Visit megaphone.fm/adchoices